GBP1 and metabolic dysfunction-associated steatotic liver disease: According to the existing research, GBP1 was repressed in hepatitis B virus‐infected patients,31 GBP2 expression levels were enhanced in patients with nonalcoholic fatty liver disease,32 and overexpression of GBP5 could induce liver injury and inflammation.33